Pyxant Labs Acquires Covance by Labcorp’s Salt Lake City Bioanalytical Site

Pyxant Labs Inc., a privately held bioanalytical contract research laboratory, announced Thursday an agreement to acquire Covance by Labcorp’s Salt Lake City bioanalytical site. Pyxant Labs’ Colorado Springs operations and the Salt Lake City site will combine their long-standing reputations, breadth of services, recognized expertise, and exclusive focus on bioanalytical services with the industry-leading cellular imaging and spatial biology capabilities of ImaBiotech.

Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an Affiliate of City of Hope

Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its previously announced acquisition of Ashion Analytics, LLC. “As a leader in cancer testing, we’re committed to providing earlier answers and life-changing treatment guidance to support patients along every step of their cancer journey,” said Kevin Conroy, chairman and CEO of Exact Sciences. “With Ashion, we’ve added a talented team, a CLIA-certified and CAP-accredited lab, deep sequencing capabilities, and one of the most comprehensive genomic cancer tests available on the market today with GEM ExTra®.”

IQVIA Acquires Remaining Interest in Q2 Solutions from Quest Diagnostics

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced the acquisition of the 40 percent minority share of Q2 Solutions from Quest Diagnostics (NYSE: DGX), the world leader in diagnostic information services, for $760 million, resulting in 100 percent ownership by IQVIA. Q2 Solutions is a leading global clinical laboratory services organization that provides comprehensive testing, project management, supply chain, biorepository and biospecimen and consent tracking solutions for clinical trials.

DiamiR Announces Acquisition of CLIA Lab from Interpace Biosciences

DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced that it has entered into a definitive agreement to acquire a CLIA (Clinical Laboratory Improvement Amendments) certified laboratory in New Haven, CT from Interpace Biosciences, Inc. Subject to specific terms and conditions of the agreement being met, it is anticipated that the transaction will close by the end of April, 2021.

Exact Sciences to Acquire Ashion Analytics

Exact Sciences Corp. (Nasdaq: EXAS) announced Tuesday that it has entered into an agreement to acquire Ashion Analytics, LLC (Ashion) from The Translational Genomics Research Institute (TGen), an affiliate of City of Hope. Ashion is a CLIA-certified and CAP-accredited sequencing lab based in Phoenix, Arizona with the genomics testing capabilities necessary to address the increasingly complex needs of clinical, academic, and biopharma customers focused on precision cancer treatments.

Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced it has acquired cell sorting technology assets from Propel Labs, a wholly-owned subsidiary of SIDIS Corp. Under the terms of the agreement, the recently introduced Bigfoot Spectral Cell Sorter and approximately 40 employees will become part of Thermo Fisher’s Biosciences business. Propel Labs will continue to operate as a separate entity and serve its existing customers.

HORIBA Acquires MedTest DX and Pointe Scientific to Expand Laboratory Chemistry Offerings

HORIBA, Ltd. (Headquarters in Kyoto, Japan, referred to as HORIBA) and HORIBA Instruments (Headquarters in Irvine, California) announced Tuesday that it has acquired MedTest Holdings, Inc. (Headquarters in Canton, MI, USA, composed of MedTest Dx, Inc., Pointe Scientific, Inc., Clinitox Diagnostix, Inc., and Medical Laboratory Solutions, Inc.). The acquisition will combine the complimentary innovative technology offerings of the HORIBA Medical segment (referred to as HORIBA Medical) with MedTest Dx technology, Clinitox, and Pointe Scientific’s R&D and manufacturing capabilities, with particular expertise in FDA 510K and CLIA clearances, to address the multidisciplinary requirements of IVD1 testing customers.

Charles River Laboratories Acquires Distributed Bio

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it acquired Distributed Bio, Inc. on December 31, 2020. The acquisition marks the culmination of an exclusive partnership between these companies that was initiated in October 2018. Based in South San Francisco, California, Distributed Bio is a next-generation antibody discovery company.

Thermo Fisher Scientific Acquires Programmable Dye Platform Pioneer Phitonex

Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research.

Eurofins Transplant Diagnostics Expands Footprint in Hawaii through the Acquisition of Hawaii Cellular Therapy and Transplant Laboratory (HCTTL)

Eurofins’ US Transplant Diagnostics is proud to announce the successful acquisition of the Hawaii Cellular Therapy and Transplant Laboratory (HCTTL). HCTTL will merge with Eurofins VRL, a market leader in US pre-transplant testing, and expand VRL’s substantial US geographic footprint. The addition of this highly regarded and long-standing pillar of the Hawaiian transplant community will further increase VRL’s network of laboratories that are now located in 11 states, serving Organ Procurement Organizations, Tissue Banks, and commercial companies needing testing for donated biological materials.